...
首页> 外文期刊>European journal of pharmaceutical sciences >Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.
【24h】

Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.

机译:外排转运蛋白ABCB1,ABCC2和ABCG2在人结直肠癌细胞系LS513中的表达和活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The human colorectal carcinoma cell line LS513 exhibits epithelial morphology, adherent properties and can grow subcutaneously to form tumors in nude mice. Thus, it is a potential model for mouse xenograft efficacy studies. The present study characterized the expression and activity of P-gp, BCRP and MRP2 in LS513 cells. We investigated the expression of these ATP-binding cassette transporters by Western blot and their activity was also examined using cell culture inserts, where the LS513 cells were grown to confluence for 9 days. The transport of model substrates of P-gp (amprenavir, ritonavir and topotecan), BCRP (topotecan) and MRP2 (SN-38) was studied in the apical to basolateral (A-B) and basolateral to apical (B-A) directions. P-gp, BCRP and MRP2 could be detected by western blot. The LS513 cells exhibited markedly higher transport in the B-A direction than in the A-B direction for the probe substrates tested, with efflux ratios (ERs; B-A/A-B) of 10, 21, 40 and 50 for amprenavir, ritonavir, topotecan and SN38, respectively. The ER could be significantly reduced with the addition of inhibitors of P-gp (GF120918), BCRP (FTC), and MRP2 (MK571), confirming the activity of these transporters in the LS513 cells.
机译:人结肠直肠癌细胞系LS513表现出上皮形态,粘附特性,并且可以在皮下生长并在裸鼠中形成肿瘤。因此,它是小鼠异种移植功效研究的潜在模型。本研究表征了P-gp,BCRP和MRP2在LS513细胞中的表达和活性。我们通过蛋白质印迹调查了这些ATP结合盒转运蛋白的表达,还使用细胞培养插入物检查了它们的活性,其中LS513细胞生长至汇合9天。研究了P-gp(amprenavir,利托那韦和托泊替康),BCRP(托泊替康)和MRP2(SN-38)的模型底物在顶向基底外侧(A-B)和基底向顶顶端(B-A)方向的运输。 Western blot检测P-gp,BCRP和MRP2。对于所测试的探针底物,LS5​​13细胞在BA方向上的转运明显高于在AB方向上的转运,氨普那韦,利托那韦,托泊替康和SN38的外流比(ERs; BA / AB)分别为10、21、40和50。 。通过添加P-gp(GF120918),BCRP(FTC)和MRP2(MK571)抑制剂可以显着降低ER,从而证实了这些转运蛋白在LS513细胞中的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号